Alle verbonden artikelen

The biological features and prognosis of breast cancer diagnosed during pregnancy: A case-control study.

Auteurs : Azim HA, Botteri E, Renne G, Dell orto P, Rotmensz N, Gentilini O, Sangalli C, Pruneri G, Di Nubila B, Locatelli M, Sotiriou C, Piccart-Gebhart M, Goldhirsch A, Viale G, Peccatori F
Jaar : 2012
Journal : Acta oncol (Stockholm)
Volume : 51(5)
Pagina's : 653-61

Liquid biopsy to test new treatment strategies in breast cancer: are we there yet?

Auteurs : Ignatiadis M, Piccart-Gebhart M
Jaar : 2012
Journal : Ann Oncol
Volume : 23(7)
Pagina's : 1653-5

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.

Auteurs : Gianni L, Dafni U, Gelber Rd, de Azambuja E, Muehlbauer S, Goldhirsch A, Untch M, Smith I, Baselga J, Jackisch C, Cameron D, Mano M, Pedrini JL, Veronesi A, Mendiola C, Pluzanska A, Semiglazov V, Vrdoljak E, Eckart MJ, Shen Z, Skiadopoulos G, Procter M, Pritchard KI, Piccart-Gebhart M, Bell R
Jaar : 2011
Journal : Lancet Oncol
Volume : 12(3)
Pagina's : 236-44

Treatment of febrile neutropenia is expensive: prevention is the answer.

Auteurs : Klastersky J, Paesmans M
Jaar : 2011
Journal : Onkologie
Volume : 34(5)
Pagina's : 226-8

New Imaging Techniques for 90Y Microsphere Radioembolization.

Auteurs : Vouche M, Vanderlinden B, Delatte P, Lemort M, Hendlisz A, Deleporte A, Garcia C, Flamen P
Jaar : 2011
Journal : J Nucl Med Radiat Ther
Volume : 2
Pagina's : 113

Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.

Auteurs : Martinelli F, Quinten C, Maringwa JT, Coens C, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, King M, Mendoza T, Osoba D, Reeve BB, Ringash J, Koch JS, Shi Q, Taphoorn MJ, Weis J, Bottomley A, + collaborators (among others :, Piccart-Gebhart M
Jaar : 2011
Journal : Expert Rev Pharmacoecon Outcomes Res
Volume : 11(5)
Pagina's : 587-99

A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study.

Auteurs : Villanueva C, Awada A, Campone M, Machiels JP, Besse T, Magherini E, Dubin F, Semiond D, Pivot X
Jaar : 2011
Journal : Eur. J. Cancer
Volume : 47(7)
Pagina's : 1037-45

Minimal residual disease and circulating tumor cells in breast cancer.

Auteurs : Ignatiadis M, Reinholz M
Jaar : 2011
Journal : Breast Cancer Res
Volume : 13(5)
Pagina's : 222

From best supportive care to early palliative care.

Auteurs : Klastersky J
Jaar : 2011
Journal : Curr Opin Oncol
Volume : 23(4)
Pagina's : 311-2

Moterhood after Breast Cancer : searching for la dolce vita. Expert Rev.

Auteurs : Azim HA, Peccatori FA, de Azambuja E, Piccart-Gebhart M
Jaar : 2011
Journal : Anticancer Res
Volume : 11(2)
Pagina's : 287-298

Lapatinib ditosylate: expanding therapeutic options for receptor tyrosine-protein kinase erbB-2-positive breast cancer.

Auteurs : Awada A, Saliba W, Bozovic-Spasojevic I
Jaar : 2011
Journal : Drugs Today (Barc)
Volume : 47(5)
Pagina's : 335-45

External quality assurance of circulating tumor cell enumeration using the CellSearch(®) system: a feasibility study.

Auteurs : Kraan J, Sleijfer S, Strijbos MH, Ignatiadis M, Peeters D, Pierga JY, Farace F, Riethdorf S, Fehm T, Zorzino L, Tibbe AG, Maestro M, Gisbert-Criado R, Denton G, de Bono JS, Dive C, Foekens JA, Gratama JW
Jaar : 2011
Journal : Cytometry B Clin Cytom
Volume : 80(2)
Pagina's : 112-8

Recurrent thyroid cancer: a molecular-based therapeutic breakthrough.

Auteurs : Lalami Y, Awada A
Jaar : 2011
Journal : Curr Opin Oncol
Volume : 23(3)
Pagina's : 235-40

Prévention et traitement des infections. (TEXTBOOK : « Thérapeutique du cancer » Morère JF, Mornex F., Soulières D. 2ème édition. Springer-Verlag, Paris, France)

Auteurs : Klastersky J, Aoun M
Jaar : 2011
Journal : Book
Volume : -
Pagina's : 151-65

Supportive care for patients with gynaecological cancer

Auteurs : Klastersky J, Lossignol D
Jaar : 2011
Journal : South Afr Gynaecol Oncol
Volume : 3
Pagina's : 9-12

A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer.

Auteurs : Mayer EL, Baurain JF, Sparano J, Strauss L, Campone M, Fumoleau P, Rugo H, Awada A, Sy O, Llombart-Cussac A
Jaar : 2011
Journal : Clin Cancer Res
Volume : 17(21)
Pagina's : 6897-6904

A rare case of a pancreatic mass due to accessory spleen; when EUS-FNA is not enough.

Auteurs : Toussaint E, Flamen P, Demetter P, Matos C, Van Gossum M, Delhaye M, Closset J, Loi P, Deviere J, Arvanitakis M
Jaar : 2011
Journal : Endoscopy
Volume : 43 Suppl 2 UCTN(null)
Pagina's : E221-2

The Research Ethics Committee at Universidade Federal de Santa Maria: a brief historical review

Auteurs : Nardin Weis L, Hundertmarck Minato E, Borges Fagundes R, Bins di Napoli R, Emando Silva C, de Campos Velho MTA, Dal Lago L
Jaar : 2011
Journal : Revista HCPA
Volume : 31(3)
Pagina's : 372-76

Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: what next?

Auteurs : Aftimos P, Awada A
Jaar : 2011
Journal : Adv Ther
Volume : 28(11)
Pagina's : 973-85

Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.

Auteurs : Necib H, Garcia C, Wagner A, Vanderlinden B, Emonts P, Hendlisz A, Flamen P, Buvat I
Jaar : 2011
Journal : J. Nucl. Med.
Volume : 52(3)
Pagina's : 354-61